Application of lipid nanoparticles to ocular drug delivery

L Battaglia, L Serpe, F Foglietta, E Muntoni… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Although eye drops are widely used as drug delivery systems for the anterior
segment of the eye, they are also associated with poor drug bioavailability due to transient …

Current drug treatments targeting dopamine D3 receptor

GM Leggio, C Bucolo, CBM Platania… - Pharmacology & …, 2016 - Elsevier
Dopamine receptors (DR) have been extensively studied, but only in recent years they
became object of investigation to elucidate the specific role of different subtypes (D1R, D2R …

[HTML][HTML] Optical coherence tomography angiography of the superficial microvasculature in the macular and peripapillary areas in glaucomatous and healthy eyes

HSL Chen, CH Liu, WC Wu, HJ Tseng… - … & visual science, 2017 - tvst.arvojournals.org
Purpose: To quantitatively evaluate the superficial microvasculature in the macular and
peripapillary areas in glaucomatous and healthy eyes using optical coherence tomography …

[HTML][HTML] Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma

A MooreLori, L LaethemCarmen… - Journal of Ocular …, 2018 - liebertpub.com
Purpose: Rho-associated protein kinase (ROCK) inhibitors lower intraocular pressure (IOP)
by increasing aqueous outflow through the trabecular meshwork (TM). The preclinical …

Anti-fibrotic activity of a rho-kinase inhibitor restores outflow function and intraocular pressure homeostasis

G Li, C Lee, AT Read, K Wang, J Ha, M Kuhn, I Navarro… - Elife, 2021 - elifesciences.org
Glucocorticoids are widely used as an ophthalmic medication. A common, sight-threatening
adverse event of glucocorticoid usage is ocular hypertension, caused by dysfunction of the …

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma

NA Sharif, N Odani-Kawabata, F Lu… - Experimental Eye …, 2023 - Elsevier
Prostaglandin (PG) receptors represent important druggable targets due to the many diverse
actions of PGs in the body. From an ocular perspective, the discovery, development, and …

Pharmacologic characterization of omidenepag isopropyl, a novel selective EP2 receptor agonist, as an ocular hypotensive agent

T Kirihara, T Taniguchi, K Yamamura… - … & Visual Science, 2018 - iovs.arvojournals.org
Purpose: The objective of this study was to investigate the pharmacologic characteristics of
omidenepag isopropyl (OMDI), a compound developed as a novel intraocular pressure …

Thermosensitive hexanoyl glycol chitosan-based ocular delivery system for glaucoma therapy

IS Cho, CG Park, BK Huh, MO Cho, Z Khatun, Z Li… - Acta Biomaterialia, 2016 - Elsevier
Conventional eye drops quickly move away from the surface of the eye; as a result, ocular
bioavailability is very limited. To overcome this issue, we developed a thermosensitive …

Development of a Δ9-tetrahydrocannabinol amino acid-dicarboxylate prodrug with improved ocular bioavailability

GR Adelli, P Bhagav, P Taskar… - … & visual science, 2017 - iovs.arvojournals.org
Purpose: The aim of the present study was to evaluate the utility of the relatively hydrophilic
Δ 9-tetrahydrocannabinol (THC) prodrugs, mono and di-valine esters (THC-Val and THC …

Novel therapeutics in glaucoma management

C Bucolo, C Platania, F Drago… - Current …, 2018 - ingentaconnect.com
Background: Glaucoma is a progressive optic neuropathy characterized by retinal ganglion
cell death and alterations of visual field. Elevated intraocular pressure (IOP) is considered …